Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.
about
G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis.Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signalingPhysiological and molecular determinants of embryo implantationChapter 15: disease gene prioritization.G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium.G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium.G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.Estrogen receptors and human disease: an update.G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growthGenetic variants of GPER/GPR30, a novel estrogen-related G protein receptor, are associated with human seminoma.Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities.Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes.Towards individualisation of treatment in endometrial cancer.Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer.Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas.Expression of G protein-coupled oestrogen receptor in melanoma and in pregnancy-associated melanoma.
P2860
Q30425896-2EC0CB7A-99D9-43D9-8893-0F45B1F2903CQ34147662-C4956BB0-0C72-4D9D-B646-BDFEC829FF85Q34320970-0306D26D-93C8-4277-9774-1FEA94670376Q34697737-B1351709-F5AF-4D35-82FC-60D061DA235AQ35543259-488CADBB-F10E-4606-93A8-BFA7C2D737E7Q36222589-42762BA7-3AD4-460A-BE69-7331A721B415Q36614226-1815C61D-45CC-4CE4-82A6-CBF894753040Q36661810-F541B9B1-3476-4D89-A590-88267A409A3AQ37393019-1999FD35-98D9-4448-89BB-ADA3C4DDD886Q37535682-60FE2684-2581-47F6-BB97-2678BE660984Q38000940-4B82D665-B8CE-4884-ABA6-7E3B2F1F90C8Q38806304-10E037A8-E204-4E14-A55C-DFD5FD87CD9AQ43168106-3E02E28C-FA30-4089-AD73-32925E9C79B0Q45738285-65FBE269-A817-45D4-94EB-D379D7AA273EQ47109592-D979EE8D-937A-4391-818B-4DCCCFF79929Q47205859-75022FB7-0B90-4ECD-B500-AFC2626FFB75Q51022629-C0043151-38AB-4D92-B25F-E8DA81113C63
P2860
Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@ast
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@en
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@nl
type
label
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@ast
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@en
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@nl
prefLabel
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@ast
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@en
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@nl
P2093
P2860
P1476
Co-expression of GPR30 and ERb ...... ion in uterine carcinosarcoma.
@en
P2093
Eric R Prossnitz
Gary L Goldberg
Gloria S Huang
Harriet O Smith
Hugo Arias-Pulido
Marc J Gunter
Rebecca C Arend
P2860
P304
P356
10.1016/J.AJOG.2010.04.046
P407
P577
2010-06-03T00:00:00Z